VpreB Activators
VPREB1 Activators represent a class of chemicals that exert influence on cellular pathways to promote the upregulation of the VPREB1 protein. This class includes compounds that inhibit enzymes critical for nucleotide synthesis, leading to a shift in cellular regulation that favors the expression of proteins involved in B cell development. Some activators function by increasing intracellular second messengers, such as cyclic AMP, which can amplify signaling pathways that drive the transcription of genes associated with early stages of B cell maturation. Others may interact with specific receptor-mediated pathways known to be involved in the regulation of components critical to the pre-B cell receptor complex.
Additionally, certain chemicals within this class can alter intracellular processes like autophagy and metabolic regulation, which can indirectly create a cellular state that supports the increased expression of pre-B cell receptor components. Modulators that impact cell survival and proliferation pathways may also play a role in the upregulation of proteins necessary for the assembly and function of the pre-B cell receptor. The class also includes agents that can influence the immune response through modulation of receptor signaling, fostering an environment that encourages B cell development and maturation. Collectively, these VPREB1 Activators can contribute to the cellular dynamics that enhance the functional presence of VPREB1 within B cells, albeit through a variety of molecular mechanisms and pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $83.00 | 5 | |
Leflunomide’s active metabolite could possibly activate VPREB1 by inhibiting the mitochondrial enzyme dihydroorotate dehydrogenase, crucial for pyrimidine synthesis. This action may promote a compensatory upregulation of other pathways to sustain B cell proliferation, which could enhance the expression of proteins involved in early B cell development, such as VPREB1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin could possibly activate VPREB1 by stimulating adenylate cyclase, thereby increasing intracellular cAMP levels. Increased cAMP may enhance B cell signaling pathways that support the expression of early B cell development genes, which could result in upregulation of VPREB1 within the pre-BCR complex. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) could possibly activate VPREB1 by interacting with EP receptors on B cells, potentially enhancing pathways that upregulate the expression of pre-BCR components, which could include VPREB1, thereby promoting its function in the pre-BCR. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $37.00 $146.00 | 3 | |
Piperine could possibly activate VPREB1 by affecting various enzymes and transporters involved in metabolic regulation. This action may lead to changes in the cellular signaling environment that increase the expression of molecules involved in B cell receptor assembly, such as VPREB1. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could possibly activate VPREB1 by modulating cellular signaling pathways, potentially promoting an environment conducive to B cell development. This could lead to upregulation of key molecules in the pre-BCR complex, including VPREB1. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could possibly activate VPREB1 by impacting pathways associated with cell survival and proliferation. Through these pathways, it may contribute to the enhancement of the B cell developmental process, potentially leading to increased activity of VPREB1 in the pre-BCR. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) could possibly activate VPREB1 by modulating lymphocyte trafficking and survival. Its signaling may support conditions favoring B cell maturation and the upregulation of pre-BCR components, including VPREB1. | ||||||
Uridine | 58-96-8 | sc-296685 sc-296685A | 1 g 25 g | $61.00 $100.00 | 1 | |
Uridine could possibly activate VPREB1 as it supports RNA synthesis when supplemented, which may enhance the transcriptional program of developing B cells, potentially increasing VPREB1 expression levels as part of the pre-BCR. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium could possibly activate VPREB1 by modulating the activity of glycogen synthase kinase-3 (GSK-3), with implications for cell development and signaling. Inhibition of GSK-3 could promote the expression of pre-BCR components, including VPREB1, enhancing its activity. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod could possibly activate VPREB1 by acting as an immune modulator, affecting Toll-like receptor signaling. This enhancement of the immune response may promote B cell development pathways that increase the expression of pre-BCR components like VPREB1 | ||||||